Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
KRd vs VRd Regimens for Multiple Myeloma
Recruiting4 awardsPhase 3
Chicago, Illinois
This trial is testing two different combinations of medications for patients who have just been diagnosed with multiple myeloma. The medications work by killing cancer cells and boosting the immune system's ability to fight the cancer. A new type of therapy has shown promising results in treating multiple myeloma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service